BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:ALDURAZYME (Laronidase) readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of ALDURAZYME (Laronidase)\, from ClinicalTr
 ials.gov estimates.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT04532047-10779@assetmemo.bio
DTSTAMP:20261121T005613Z
DTSTART;VALUE=DATE:20310731
DTEND;VALUE=DATE:20310801
SUMMARY:ALDURAZYME (Laronidase): Phase 1 readout est. (NCT04532047)
DESCRIPTION:ALDURAZYME (Laronidase)\, phase 1.\nStudy: PEARL (PrEnAtal Enzy
 me Replacement Therapy for Lysosomal Storage Disorders)\nEstimated primary
  completion: 31 July 2031. This is a ClinicalTrials.gov estimate\, not a c
 onfirmed readout date\, and it can move.\nDrug page: https://assetmemo.bio
 /drug/laronidase#upcoming-events\nRegistry record: https://clinicaltrials.
 gov/study/NCT04532047
URL:https://assetmemo.bio/drug/laronidase#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
